Home  »  Hot Stocks   »  Revelation Biosciences Inc. (REVB): Skating on Thi...

Revelation Biosciences Inc. (REVB): Skating on Thin Ice? We Know the Answer

Revelation Biosciences Inc. (NASDAQ:REVB) went up by 7.53% from its latest closing price compared to the recent 1-year high of $3.30. The company’s stock price has collected -4.16% of loss in the last five trading sessions.

Is It Worth Investing in Revelation Biosciences Inc. (NASDAQ :REVB) Right Now?

Opinions of the stock are interesting as 1 analysts out of 1 who provided ratings for Revelation Biosciences Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.


The average price from analysts is $5.00, which is $4.74 above the current price. REVB currently public float of 17.26M and currently shorts hold a 9.64% ratio of that float. Today, the average trading volume of REVB was 1.67M shares.

REVB’s Market Performance

REVB stocks went down by -4.16% for the week, with a monthly jump of 26.46% and a quarterly performance of 7.94%, while its annual performance rate touched -92.23%. The volatility ratio for the week stands at 14.55% while the volatility levels for the past 30 days are set at 15.28% for Revelation Biosciences Inc. The simple moving average for the period of the last 20 days is 16.68% for REVB stocks with a simple moving average of -47.80% for the last 200 days.

REVB Trading at 18.13% from the 50-Day Moving Average

After a stumble in the market that brought REVB to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -92.25% of loss for the given period.

Volatility was left at 15.28%, however, over the last 30 days, the volatility rate increased by 14.55%, as shares surge +28.11% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +25.22% upper at present.

During the last 5 trading sessions, REVB fell by -4.16%, which changed the moving average for the period of 200-days by -76.75% in comparison to the 20-day moving average, which settled at $0.2219. In addition, Revelation Biosciences Inc. saw 34.51% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at REVB starting from TIDMARSH GEORGE F, who purchase 20,000 shares at the price of $1.60 back on Feb 25. After this action, TIDMARSH GEORGE F now owns 467,156 shares of Revelation Biosciences Inc., valued at $32,000 using the latest closing price.

Stock Fundamentals for REVB

Equity return is now at value 739.20, with -259.60 for asset returns.

The liquidity ratio also appears to be rather interesting for investors as it stands at 0.02.

5 Lithium Stocks with High Future Potential

Demand for lithium is expected to increase 8-fold by 2030. The world's largest automakers are racing to go green as the global EV boom continues.


We have collated a list of top five lithium stocks which are well positioned to benefit from the 2023 lithium boom because of their focus on multiple high-potential lithium projects.

100% free. stop anytime no spam